檢索結果 - Stelmasiak, Zbigniew

Standards in neurosonology. Part II 由 Wojczal, Joanna, Tomczyk, Tomasz, Luchowski, Piotr, Kozera, Grzegorz, Kaźmierski, Radosław, Stelmasiak, Zbigniew

獲取全文 獲取全文 獲取全文

Standards in neurosonology. Part III 由 Wojczal, Joanna, Tomczyk, Tomasz, Luchowski, Piotr, Kozera, Grzegorz, Kaźmierski, Radosław, Stelmasiak, Zbigniew

獲取全文 獲取全文 獲取全文

Long-Term Safety and Efficacy of Subcutaneous Cladribine Used in Increased Dosage in Patients with Relapsing Multiple Sclerosis: 20-Year Observational Study 由 Rejdak, Konrad, Zasybska, Adriana, Pietruczuk, Aleksandra, Baranowski, Dariusz, Szklener, Sebastian, Kaczmarek, Magda, Stelmasiak, Zbigniew

獲取全文 獲取全文 獲取全文

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA stu... 由 Léger, Jean-Marc, De Bleecker, Jan L, Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Shebl, Amgad, Bauhofer, Artur, Zenker, Othmar, Merkies, Ingemar S J

獲取全文 獲取全文 獲取全文

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial 由 Merkies, Ingemar S. J., Lawo, John‐Philip, Edelman, Jonathan M., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Léger, Jean‐Marc

獲取全文 獲取全文 獲取全文

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies 由 Merkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean‐Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell

獲取全文 獲取全文 獲取全文